FI915826A - Farmaceutiska aemnen. - Google Patents

Farmaceutiska aemnen. Download PDF

Info

Publication number
FI915826A
FI915826A FI915826A FI915826A FI915826A FI 915826 A FI915826 A FI 915826A FI 915826 A FI915826 A FI 915826A FI 915826 A FI915826 A FI 915826A FI 915826 A FI915826 A FI 915826A
Authority
FI
Finland
Prior art keywords
aemnen
pharmaceutical
pharmaceutical aemnen
Prior art date
Application number
FI915826A
Other languages
English (en)
Other versions
FI101193B (fi
FI915826A0 (fi
FI101193B1 (fi
Inventor
James Joseph Holohan
Ieuan John Edwards
Robert Joseph Timko
Randy John Bradway
Arlene Clements
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI915826(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909027014A external-priority patent/GB9027014D0/en
Priority claimed from GB919115107A external-priority patent/GB9115107D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI915826A0 publication Critical patent/FI915826A0/fi
Publication of FI915826A publication Critical patent/FI915826A/fi
Priority to FI972528A priority Critical patent/FI106021B/fi
Priority to FI980376A priority patent/FI980376A/fi
Application granted granted Critical
Publication of FI101193B publication Critical patent/FI101193B/fi
Publication of FI101193B1 publication Critical patent/FI101193B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
FI915826A 1990-12-12 1991-12-11 Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseksi FI101193B1 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI972528A FI106021B (fi) 1990-12-12 1997-06-13 Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
FI980376A FI980376A (fi) 1990-12-12 1998-02-18 N-/4-/5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli/-3-metoksibentsoyyli/-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävä farmaseuttinen koostumus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027014A GB9027014D0 (en) 1990-12-12 1990-12-12 Pharmaceutical agents
GB919115107A GB9115107D0 (en) 1991-07-12 1991-07-12 Pharmaceutical agents

Publications (4)

Publication Number Publication Date
FI915826A0 FI915826A0 (fi) 1991-12-11
FI915826A true FI915826A (fi) 1992-03-31
FI101193B FI101193B (fi) 1998-05-15
FI101193B1 FI101193B1 (fi) 1998-05-15

Family

ID=26298105

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915826A FI101193B1 (fi) 1990-12-12 1991-12-11 Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseksi

Country Status (30)

Country Link
US (6) US5319097A (fi)
EP (1) EP0490648B1 (fi)
JP (1) JP2585495B2 (fi)
KR (2) KR0183027B1 (fi)
CN (2) CN1043405C (fi)
AP (1) AP285A (fi)
AT (1) ATE131048T1 (fi)
AU (1) AU656157B2 (fi)
BE (1) BE1004229A5 (fi)
CA (2) CA2056066C (fi)
CZ (1) CZ283181B6 (fi)
DE (2) DE69115229T2 (fi)
DK (1) DK0490648T3 (fi)
ES (1) ES2079589T3 (fi)
FI (1) FI101193B1 (fi)
FR (1) FR2670488B1 (fi)
GB (2) GB2251791B (fi)
GR (1) GR3018318T3 (fi)
HK (2) HK81397A (fi)
HU (2) HU213211B (fi)
IE (1) IE75348B1 (fi)
IL (1) IL100091A (fi)
IT (1) IT1256282B (fi)
MX (1) MX9102473A (fi)
MY (1) MY106315A (fi)
NZ (1) NZ240939A (fi)
PH (1) PH30928A (fi)
RU (1) RU2106140C1 (fi)
SK (2) SK279813B6 (fi)
TW (1) TW276181B (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
DE9410461U1 (de) * 1994-07-01 1994-09-22 Merck Patent Gmbh Mittel für die Röntgenfluoreszenzanalyse
US6279736B1 (en) 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
IN182496B (fi) * 1996-02-20 1999-04-17 Reddy Research Foundation
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
KR100283682B1 (ko) * 1998-07-14 2001-03-02 조정래 열풍건조장치
US6253463B1 (en) 1999-04-26 2001-07-03 Niro A/S Method of spray drying
IN191496B (fi) 1999-07-30 2003-12-06 Ranbaxy Lab Ltd
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
IL140096A0 (en) * 2000-12-05 2002-02-10 Internat Specialty Products Is Process for preparation of zafirlukast
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
HUP0303915A3 (en) * 2001-01-26 2012-12-28 Merck Sharp & Dohme Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
WO2003006441A1 (en) * 2001-07-10 2003-01-23 Pharmacia & Upjohn Company Crystalline thiazine oxazolidinones
PT3168218T (pt) * 2001-08-15 2019-01-11 Pharmacia & Upjohn Co Llc Um cristal compreendendo um sal de ácido l-málico de n-[2- (dietilamino)etil]-5-[(5-fluoro-1,2-dihidro-2-oxo-3h-indol- 3-ilideno)metil]-2,4-dimetil-1h-pirrol-3-carboxamida para utilização como um medicamento
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DK1429756T3 (da) * 2001-09-21 2007-03-19 Schering Corp Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
CN1756756A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
ITMI20041032A1 (it) * 2004-05-24 2004-08-24 Neuroscienze S C A R L Compositi farmaceutici
JP2008531721A (ja) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド 複素環式アミド誘導体のナノ粒子状組成物
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090191183A1 (en) * 2007-07-30 2009-07-30 Auspex Pharmaceuticals, Inc. Substituted indoles
US20090149662A1 (en) * 2007-12-05 2009-06-11 Raghupathi Reddy Anumula Processes for preparing zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
JP2017503814A (ja) 2014-01-22 2017-02-02 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のｐｄｅ４インヒビターを用いた（およびロイコトリエン調節薬と組み合わせて用いた）治療
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
WO2019130334A1 (en) 2017-12-28 2019-07-04 Council Of Scientific & Industrial Research Process for the preparation of zafirlukast and analogs thereof
CA3219671A1 (en) 2021-05-19 2022-11-24 Thomas Christian Lines Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
US5482963A (en) 1996-01-09
HK81597A (en) 1997-06-27
NZ240939A (en) 1994-05-26
SK279813B6 (sk) 1999-04-13
IL100091A (en) 1998-08-16
KR100207802B1 (ko) 1999-07-15
GB9126354D0 (en) 1992-02-12
AP9100340A0 (en) 1992-01-31
IT1256282B (it) 1995-11-29
KR0183027B1 (ko) 1999-05-01
MY106315A (en) 1995-04-29
AU8899491A (en) 1992-06-18
FR2670488A1 (fr) 1992-06-19
JP2585495B2 (ja) 1997-02-26
AU656157B2 (en) 1995-01-27
CN1105705C (zh) 2003-04-16
IE914310A1 (en) 1992-06-17
FI101193B (fi) 1998-05-15
SK279814B6 (sk) 1999-04-13
HU213211B (en) 1997-03-28
BE1004229A5 (fr) 1992-10-13
DE4140858A1 (de) 1992-06-17
US5319097A (en) 1994-06-07
JPH04266824A (ja) 1992-09-22
GB2251791B (en) 1995-05-17
MX9102473A (es) 1992-06-01
CA2319308C (en) 2001-08-21
CN1043405C (zh) 1999-05-19
GB2251791A (en) 1992-07-22
DK0490648T3 (da) 1996-05-06
CN1062291A (zh) 1992-07-01
GB9418154D0 (en) 1994-10-26
TW276181B (fi) 1996-05-21
HUT61281A (en) 1992-12-28
ITMI913324A1 (it) 1993-06-11
FI915826A0 (fi) 1991-12-11
KR970005014A (ko) 1997-01-29
IL100091A0 (en) 1992-08-18
CS375691A3 (en) 1992-06-17
CN1243827A (zh) 2000-02-09
US5504216A (en) 1996-04-02
EP0490648A1 (en) 1992-06-17
US5993859A (en) 1999-11-30
FI101193B1 (fi) 1998-05-15
ITMI913324A0 (it) 1991-12-11
KR920011493A (ko) 1992-07-24
GR3018318T3 (en) 1996-03-31
CA2056066A1 (en) 1992-06-13
DE69115229T2 (de) 1996-05-09
AP285A (en) 1993-09-23
US5612367A (en) 1997-03-18
PH30928A (en) 1997-12-23
EP0490648B1 (en) 1995-12-06
GB2280606B (en) 1995-05-17
GB2280606A (en) 1995-02-08
IE75348B1 (en) 1997-08-27
DE69115229D1 (de) 1996-01-18
CA2319308A1 (en) 1992-06-13
CA2056066C (en) 2002-04-02
US6143775A (en) 2000-11-07
HU913865D0 (en) 1992-02-28
ATE131048T1 (de) 1995-12-15
HU211126A9 (en) 1995-10-30
HK81397A (en) 1997-06-27
ES2079589T3 (es) 1996-01-16
CZ283181B6 (cs) 1998-01-14
FR2670488B1 (fr) 1994-01-28
RU2106140C1 (ru) 1998-03-10

Similar Documents

Publication Publication Date Title
FI915826A0 (fi) Farmaceutiska aemnen.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
NO912799L (no) Foradditiver for droevtyggere.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
DE69112037D1 (de) Waferträger.
DE69111876T2 (de) Ophthalmometer.
DE59104521D1 (de) Polkern.
FI86263B (fi) Skaer- och slipanordning foer en glasskivkant.
FI86244B (fi) Bakugn-spisugnkombination.
FI87009B (fi) Skovelhjul foer centrifugalpumpar.
DE69100071D1 (de) Kaefigmutter.
FI923371A0 (fi) En farmaceutisk formulation.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
FI900028A (fi) Belaeggningsmaterial.
DE59103525D1 (de) Honmachine.
DE69104797D1 (de) 2-Substituierte-1-Hydroxyindole.
ES1012467Y (es) Huevera.
ES1015228Y (es) Kiosko.
ES1014023Y (es) Traca pirotecnica.
ES1014067Y (es) Caja-expositor.
ES1014363Y (es) Tendedero antilluvia.
ES1014476Y (es) Cubitera.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ZENECA LIMITED

MA Patent expired